Early postoperative plasma circulating tumour DNA for molecular residue disease detection and recurrence risk evaluation in surgical non-small cell lung cancer
This study was supported by the Yunnan Provincial
Department of Science and Technology Foundation for
Youths (202301AU070195) and Scientific Research Foundation for Doctors, the First Affiliated Hospital of Kunming
Medical University (2021BS017) to Xudong Yang
第一作者机构：[1]Kunming Med Univ, Affiliated Hosp 1, Dept Thorac Surg, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China
通讯作者：
通讯机构：[1]Kunming Med Univ, Affiliated Hosp 1, Dept Thorac Surg, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China[*1]Department of Thoracic Surgery, The First Affiliated Hospital of Kunming Medical University, No.295 Xichang Road, Kunming 650032, Yunnan, China
推荐引用方式(GB/T 7714)：
Tang Jie,Tian Yingsong,Wang Song,et al.Early postoperative plasma circulating tumour DNA for molecular residue disease detection and recurrence risk evaluation in surgical non-small cell lung cancer[J].CLINICAL AND TRANSLATIONAL MEDICINE.2024,14(10):doi:10.1002/ctm2.70056.
APA：
Tang, Jie,Tian, Yingsong,Wang, Song,Liu, Yong,Chen, Manjun...&Chen, Xiaobo.(2024).Early postoperative plasma circulating tumour DNA for molecular residue disease detection and recurrence risk evaluation in surgical non-small cell lung cancer.CLINICAL AND TRANSLATIONAL MEDICINE,14,(10)
MLA：
Tang, Jie,et al."Early postoperative plasma circulating tumour DNA for molecular residue disease detection and recurrence risk evaluation in surgical non-small cell lung cancer".CLINICAL AND TRANSLATIONAL MEDICINE 14..10(2024)
